Welcome to
Where we revolutionize the field of
bone regeneration through cutting-edge science.
revolutionize the
field of bone regeneration through cutting-edge science.
Our Company
OrthoTreat specializes in developing technologies for bone regeneration and various related conditions. We’ve pioneered a novel approach that meticulously oversees the intricate processes of bone regeneration and maintenance, creating a balanced, modulated system with significant clinical impact.
Our Mission
To provide a safe and highly efficient treatment option that accelerates healing, enhances bone quality, and benefits “broken” individuals around the globe.
ModulX®
A dual-drug combination therapy, controlled released and locally injected, with minimal risk factors, integrating:
- Balanced immune response regulation
- Sophisticated inflammation control
- Highly modulated and precisely calibrated growth factor secretion
Exerts anti-inflammatory action via inhibition of various cytokines and chemokines.
Improved and
accelerated healing.
Thereby achieving accelerated, optimal healing throughout the healing period
The Science
Over the last centuries,
bone healing methods
have not undergone any significant improvement.
This fact drove us to believe that a change is possible.
But even more so –
it’s necessary.
Stronger, Smarter & Better Together
Combination of 2 Active Pharmaceutical Ingredients
Stronger, Smarter
& Better Together
Combination of 2 Active Pharmaceutical Ingredients
- BCP
- LOV
- BCP+LOV
β-caryophyllene [BCP]
An inflammation-modulating antioxidative agent, a highly selective CB2 agonist approved as GRAS (Generally Recognized as Safe).
- Stimulates osteoblast bone mineralization
- Suppresses adipogenesis
- Suppresses osteo-clastogenesis
Lovastatin [LOV]
A lipid-lowering medication, part of the statin drug class. Positively affects bone healing and regeneration by controlling the expression of important proteins and biochemical pathways.
- Stimulate angiogenesis
- Osteoblast differentiation
- Promotes bone formation
BCP + LOV
Initiates a favorable cascade
of events, leading to bone regeneration and high-quality bone tissue formation.
Initiates a favorable
cascade of events, leading to bone regeneration and high-quality bone tissue formation.
- BCP
- LOV
- BCP+
LOV
β-caryophyllene [BCP]
An inflammation-modulating antioxidative agent, a highly selective CB2 agonist approved as GRAS (Generally Recognized as Safe).
- Stimulates osteoblast bone mineralization
- Suppresses adipogenesis
- Suppresses osteo-clastogenesis
Lovastatin [LOV]
A lipid-lowering medication, part of the statin drug class. Positively affects bone healing and regeneration by controlling the expression of important proteins and biochemical pathways.
- Stimulate angiogenesis
- Osteoblast differentiation
- Promotes bone formation
LOV
BCP + LOV
Initiates a favorable cascade
of events, leading to bone regeneration and high-quality bone tissue formation.
Initiates a favorable
cascade of events, leading to bone regeneration and high-quality bone tissue formation.
About Us
Long Story Short
Our genesis entails the coming together of a group of individuals mired by personal medical challenges, coupled with scientific curiosity and strong passion, conviction and belief.
Dr. Marom’s injury during his military service spurred his quest for bone healing advancements as a researcher in a bone laboratory.
Dr. Ehrmann-Barr’s own battle with injury in the service has shaped her character, amplifying a heartfelt commitment to OrthoTreat’s mission, to restore both mobility and quality of life to wounded individuals.
Likewise, our CEO, Sahar’s encounter with reoccurring sports injuries, planted the seed
of urgency for a better solution.
United by this common vision and passion, and supported by a strong professional team, the founders embarked on the mission to harness the complex orchestra of physiological processes to create a remedy that enhances and accelerates musculoskeletal recovery. This quest led to a major breakthrough: Our flagship technology, ModulX® a revolutionary drug with an unparalleled potential in the bone-healing segment.
Our genesis entails the coming together of a group of individuals mired by personal medical challenges, coupled with scientific curiosity and strong passion, conviction and belief.
Dr. Marom’s injury during his military service spurred his quest for bone healing advancements as a researcher in a bone laboratory.
Dr. Ehrmann-Barr’s own battle with injury in the service has shaped her character, amplifying a heartfelt commitment to OrthoTreat’s mission, to restore both mobility and quality of life to wounded individuals.
Likewise, our CEO, Sahar’s encounter with reoccurring sports injuries, planted the seed of urgency for a better solution.
United by this common vision and passion, and supported by a strong professional team, the founders embarked on the mission to harness the complex orchestra of physiological processes to create a remedy that enhances and accelerates musculoskeletal recovery.
This quest led to a major breakthrough: Our flagship technology, ModulX® a revolutionary drug with an unparalleled potential in the bone-healing segment.